Related Experiment Video
Updated: Sep 11, 2025

04:18
Author Spotlight: Exploring Cloning Techniques for Full-Length DNA Fragments
Published on: May 17, 2024
715
Lycopene Inhibits PRRSV Replication by Suppressing ROS Production
Ying-Xian Ma1,2,3, Ya-Qi Han1,2,3, Pei-Zhu Wang1,2,3
1College of Veterinary Medicine, Henan Agricultural University, Zhengzhou 450046, China.
International Journal of Molecular Sciences
|August 14, 2025
Summary
Lycopene effectively inhibits Porcine reproductive and respiratory syndrome virus (PRRSV) replication by reducing reactive oxygen species (ROS) and inflammation. This natural compound shows promise as a safe antiviral therapeutic for swine production.
Area of Science:
- Veterinary Virology
- Antiviral Research
- Molecular Biology
Background:
- Porcine reproductive and respiratory syndrome virus (PRRSV) significantly impacts global swine production.
- Current vaccines for PRRSV have limitations in efficacy and safety, necessitating new antiviral strategies.
Purpose of the Study:
- To investigate the molecular mechanisms underlying lycopene's inhibition of PRRSV replication.
- To evaluate lycopene's potential as a novel antiviral therapeutic agent against PRRSV.
Main Methods:
- Cell viability, cell cycle, and apoptosis assays were performed.
- Antiviral activity was assessed using fluorescence microscopy, flow cytometry, qRT-PCR, and viral titration.
- Mechanisms involving reactive oxygen species (ROS) and inflammatory responses were analyzed via immunoblotting, ELISA, and qRT-PCR.
Main Results:
- Lycopene demonstrated potent antiviral activity against PRRSV without affecting cellular health.
- Lycopene suppressed PRRSV-induced reactive oxygen species (ROS) production.
- Lycopene attenuated PRRSV-mediated inflammatory responses.
Conclusions:
- Lycopene inhibits PRRSV replication by modulating ROS levels and mitigating inflammation.
- Lycopene represents a promising, safe, and effective antiviral agent for combating PRRSV infections in swine.
More Related Videos
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
5.4K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.4K
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
Mechanisms of Retrovirus-induced Cancers
5.3K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.3K
RNA Interference
26.4K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.4K
siRNA - Small Interfering RNAs
17.0K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.0K

